TY - JOUR AU - Yan, Min AU - Bian, Li AU - Hu, Xichun AU - Zhang, Qingyuan AU - Ouyang, Quchang AU - Feng, Jifeng AU - Yin, Yongmei AU - Sun, Tao AU - Tong, Zhongsheng AU - Wang, Xiaojia AU - Yao, Herui AU - Zou, Jianjun AU - Zhu, Xiaoyu AU - Jiang, Zefei PY - 2020 TI - Pyrotinib plus capecitabine for human epidermal factor receptor 2-positive metastatic breast cancer after trastuzumab and taxanes (PHENIX): a randomized, double-blind, placebo-controlled phase 3 study JF - Translational Breast Cancer Research; Vol 1 (July 2020): Translational Breast Cancer Research Y2 - 2020 KW - N2 - UR - https://tbcr.amegroups.org/article/view/41552